Feedback / Questions
valiltramiprosate (ALZ-801) - Alzheon
https://www.businesswire.com/news/home/20240430939765/en/Alzheon-Announces-First-Patient-Dosed-in-Long-Term-Extension-of-APOLLOE4-Phase-3-Trial-of-Oral-ALZ-801Valiltramiprosate-and-Launches-52-Week-Extension-of-Phase-2-Biomarker-Trial-in-Patients-with-Early-Alzheimer%E2%80%99s-Disease
Apr 30, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next